American Society for Reproductive Medicine, Birmingham, Alabama.
Fertil Steril. 2020 Feb;113(2):305-322. doi: 10.1016/j.fertnstert.2019.10.014.
To provide evidence-based recommendations to practicing physicians and others regarding the effectiveness and safety of therapies for unexplained infertility.
ASRM conducted a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and prospective and retrospective comparative observational studies published from 1968 through 2019. The ASRM Practice Committee and a task force of experts used available evidence and informal consensus to develop evidence-based guideline recommendations.
MAIN OUTCOME MEASURE(S): Outcomes of interest included: live-birth rate, clinical pregnancy rate, implantation rate, fertilization rate, multiple pregnancy rate, dose of treatment, rate of ovarian hyperstimulation, abortion rate, and ectopic pregnancy rate.
RESULT(S): The literature search identified 88 relevant studies to inform the evidence base for this guideline.
RECOMMENDATION(S): Evidence-based recommendations were developed for the following treatments for couples with unexplained infertility: natural cycle with intrauterine insemination (IUI); clomiphene citrate with intercourse; aromatase inhibitors with intercourse; gonadotropins with intercourse; clomiphene citrate with IUI; aromatase inhibitors with IUI; combination of clomiphene citrate or letrozole and gonadotropins (low dose and conventional dose) with IUI; low-dose gonadotropins with IUI; conventional-dose gonadotropins with IUI; timing of IUI; and in vitro fertilization and treatment paradigms.
CONCLUSION(S): The treatment of unexplained infertility is by necessity empiric. For most couples, the best initial therapy is a course (typically 3 or 4 cycles) of ovarian stimulation with oral medications and intrauterine insemination (OS-IUI) followed by in vitro fertilization for those unsuccessful with OS-IUI treatments.
为执业医师和其他人员提供有关不明原因不孕治疗方法的有效性和安全性的循证建议。
美国生殖医学学会进行了文献检索,其中包括系统评价、荟萃分析、随机对照试验以及 1968 年至 2019 年发表的前瞻性和回顾性比较观察性研究。美国生殖医学学会实践委员会和一个专家工作组利用现有证据和非正式共识制定了循证指南建议。
感兴趣的结局包括:活产率、临床妊娠率、着床率、受精率、多胎妊娠率、治疗剂量、卵巢过度刺激率、流产率和异位妊娠率。
文献检索确定了 88 项相关研究,为该指南的循证基础提供了信息。
为以下治疗方案制定了基于证据的建议,用于治疗不明原因不孕的夫妇:自然周期加宫腔内人工授精(IUI);枸橼酸氯米酚加性交;芳香化酶抑制剂加性交;促性腺激素加性交;枸橼酸氯米酚加 IUI;芳香化酶抑制剂加 IUI;枸橼酸氯米酚或来曲唑联合低剂量和常规剂量促性腺激素加 IUI;低剂量促性腺激素加 IUI;常规剂量促性腺激素加 IUI;IUI 的时机;以及体外受精和治疗方案。
不明原因不孕的治疗必然是经验性的。对于大多数夫妇来说,最佳的初始治疗方法是口服药物和宫腔内人工授精(OS-IUI)卵巢刺激(通常为 3 或 4 个周期),然后对 OS-IUI 治疗不成功的患者进行体外受精。